Darmstadt-based pharmaceutical and technology company Merck is showing initial signs of technical stabilization following an extended period of weakness. Currently trading at approximately €135, the ...

Vaccinex, Inc. (OTC: VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative ...

Vaccinex intends to file a Form 25 with the Securities and Exchange Commission on or about March 17, 2025 to remove its Common Stock from listing on Nasdaq.